USP 382: Audit Readiness for Parenteral Closure Systems

Introduction

During GMP audits and regulatory inspections, parenteral closure systems are considered critical quality elements. USP 382 is often used as an implicit inspection reference.

Regulatory Alignment

USP 382 aligns with:

• EU GMP Annex 1 (container closure integrity)
• The risk-based approach of ICH Q9
• Lifecycle management principles of ICH Q12

What Inspectors Look For

• Evidence of functional suitability
• Tests consistent with real-use conditions
• Justified acceptance criteria
• Effective change management

Real Example
Fragmentation testing performed, but without a compliant microscope → finding.

How to Avoid Critical Deviations

• Integrate USP 382 into the PQS
• Link testing activities to risk assessment
• Involve QA from the early stages

Essential Documentation

• Qualification protocol
• Test reports
• Risk assessment
• Change control records
• Supplier agreements

Typical Error / Corrective Action

Error: Acceptance criteria not justified
Action: Document the technical rationale and intended use

Being audit-ready for USP 382 means protecting the product, the patient, and the company.

Keep your organization audit-ready. Discover the complete guide on GuideGxP.com